Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.
about
Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@en
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@nl
type
label
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@en
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@nl
prefLabel
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@en
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@nl
P2093
P2860
P1433
P1476
Concurrent chemoradiotherapy w ...... taxel for T2N0 glottic cancer.
@en
P2093
Atsushi Musha
Jun-Ichi Saitoh
Katsumasa Takahashi
Katsuyuki Shirai
Kazuaki Chikamatsu
Masato Shino
Masumi Imaeda
Takanori Abe
Takashi Nakano
Yukihiro Takayasu
P2860
P2888
P356
10.1186/S13014-016-0741-4
P577
2017-02-20T00:00:00Z
P6179
1083851311